Are doctors still prescribing too many opioids?

Last week, Ottawa and provincial governments reached a $150-million settlement with Purdue Pharma Canada for the recovery of health-care costs related to the sale and marketing of opioid-based pain medication. Officials claimed Purdue Pharma, the maker of OxyContin, downplayed the risks of its drugs when advertising them to physicians, especially when it comes to their addictive potential, contributing to the opioid crisis.